(Q36810269)

16 August 2017

1 reference

title

Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure (English)

1 reference

16 August 2017

1 reference

1 reference

chronic heart failure

1 reference

Shaker A Mousa

1

1 reference

16 August 2017

Olga Goncharuk

series ordinal

2

1 reference

16 August 2017

Danny Miller

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Biological Therapy

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

617-625

1 reference

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.617

21 January 2018

Identifiers

DOI

10.1517/14712598.7.5.617

1 reference

16 August 2017

1 reference